Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Campion

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Canadian Journal of Kidney Health and Disease|June 16, 2017
Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic NephropathyCarole G Campion, Oraly Sanchez-Ferras, Sri N Batchu
Frontiers in Oncology|March 26, 2021
Does Subtelomeric Position of COMMD5 Influence Cancer Progression?Carole G Campion, Thomas Verissimo, Suzanne Cossette, et al.
Plos One|August 23, 2013
Expression of galectin-7 is induced in breast cancer cells by mutant p53Carole G Campion, Marilyne Labrie, Geneviève Lavoie, et al.
Plos One|May 3, 2014
The CCAAT/enhancer-binding protein beta-2 isoform (CEBPβ-2) upregulates galectin-7 expression in human breast cancer cellsCarole G Campion, Marilyne Labrie, Andrée-Anne Grosset, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 1, 1990
Metabolism and pharmacokinetics of nufenoxole in animals and humans: an example of stereospecific hydroxylation of an isoquinuclidine ringC S Cook, J G Campion, J D Hribar, et al.
Clinical Medicine (London, England)|August 27, 2003
Impact of the two-week referral guideline on time to diagnosis and treatment in oesophago-gastric cancerR F A Logan, M W H Behan, G Campion, et al.
The FEBS Journal|September 13, 2008
Transcription factors Sp1 and C/EBP regulate NRAMP1 gene expressionEtienne Richer, Carole G Campion, Basel Dabbas, et al.
Agents and Actions. Supplements|January 1, 1992
Metabolism and characterisation of kinins and Hoe 140 (kinin antagonist) in the synovial fluid of patients with inflammatory joint diseasesA P Bond, G Breipohl, K Worthy, et al.
Medicine|March 1, 1990
The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associationsG Campion, P J Maddison, N Goulding, et al.
Human Immunology|August 1, 1987
HLA DQ alpha and DQ beta restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritisD M Sansom, J L Bidwell, P J Maddison, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Canadian Journal of Kidney Health and Disease|June 16, 2017
Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic NephropathyCarole G Campion, Oraly Sanchez-Ferras, Sri N Batchu
Frontiers in Oncology|March 26, 2021
Does Subtelomeric Position of COMMD5 Influence Cancer Progression?Carole G Campion, Thomas Verissimo, Suzanne Cossette, et al.
Plos One|August 23, 2013
Expression of galectin-7 is induced in breast cancer cells by mutant p53Carole G Campion, Marilyne Labrie, Geneviève Lavoie, et al.
Plos One|May 3, 2014
The CCAAT/enhancer-binding protein beta-2 isoform (CEBPβ-2) upregulates galectin-7 expression in human breast cancer cellsCarole G Campion, Marilyne Labrie, Andrée-Anne Grosset, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 1, 1990
Metabolism and pharmacokinetics of nufenoxole in animals and humans: an example of stereospecific hydroxylation of an isoquinuclidine ringC S Cook, J G Campion, J D Hribar, et al.
Clinical Medicine (London, England)|August 27, 2003
Impact of the two-week referral guideline on time to diagnosis and treatment in oesophago-gastric cancerR F A Logan, M W H Behan, G Campion, et al.
The FEBS Journal|September 13, 2008
Transcription factors Sp1 and C/EBP regulate NRAMP1 gene expressionEtienne Richer, Carole G Campion, Basel Dabbas, et al.
Agents and Actions. Supplements|January 1, 1992
Metabolism and characterisation of kinins and Hoe 140 (kinin antagonist) in the synovial fluid of patients with inflammatory joint diseasesA P Bond, G Breipohl, K Worthy, et al.
Medicine|March 1, 1990
The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associationsG Campion, P J Maddison, N Goulding, et al.
Human Immunology|August 1, 1987
HLA DQ alpha and DQ beta restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritisD M Sansom, J L Bidwell, P J Maddison, et al.
Pageof 3